Literature DB >> 27752904

Influence of position and radiation technique on organs at risk in radiotherapy of rectal cancer.

Jun-Feng Wang1, Hui Li2, Hua Xiong1, He Huang1, Yan-Mei Zou3.   

Abstract

The influence of the position and radiation technique on the organs at risk (OARs) in radiotherapy of rectal cancer was evaluated. The relationship between the volume of irradiated small bowel (VSB) and acute bowel toxicity was determined. A total of 97 cases of rectal cancer were retrospectively randomized to receive radiotherapy with the designated treatment positions and radiation plans. Among 64 patients in the supine position, 32 patients were given three-dimensional conformal radiotherapy (3DCR) and 32 patients were subjected to intensity-modulated radiation therapy (IMRT) respectively. The rest 33 patients were treated with 3DCRT in the prone position with a belly board. The VSB was calculated for doses from 5 to 45 Gy at an interval of 5 Gy. With prescription dose in planned target volume (PTV) of 50 Gy, the dose distribution, conformal index for PTV (CIPTV), dose-volume histogram (DVH) of OARs, the correlation of VSB and the acute toxicity were compared. The results were shown as follows: (1) Among the 3 methods, there were no differences in PTV's converge including V95 and D95; (2) For IMRT under a supine position, CIPTV was closest to 1, the mean dose of small bowel decreased (P<0.05), and the mean VSB from V30 to V45 significantly decreased (P<0.05). (3) For 3DCRT with a belly board under a prone position, the mean dose and the mean VSB from 40 to 45 Gy were less than those for 3DCRT under a supine position (P<0.05); (4) Mean proportion of VSB was significantly greater in the patients experiencing diarrhea grade 2-4 than in those with diarrhea grade 0-1 at dose levels from V30 to V45 (P<0.05). It was concluded that for the radiotherapy of rectal cancer, IMRT technique might decrease the high-dose VSB to reduce the risk of acute injury. 3DCRT with a belly board under a prone position is superior to 3DCRT under a supine position, which could be a second choice for radiation of rectal cancer.

Entities:  

Keywords:  intensity-modulated radiation therapy; prone position; radiation; rectal cancer; small bowel injury; supine position; three-dimensional conformal radiotherapy

Mesh:

Year:  2016        PMID: 27752904     DOI: 10.1007/s11596-016-1655-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

1.  Risk factors related to interfractional variation in whole pelvic irradiation for locally advanced pelvic malignancies.

Authors:  W S Yoon; D S Yang; J A Lee; S Lee; Y J Park; C Y Kim
Journal:  Strahlenther Onkol       Date:  2012-02-10       Impact factor: 3.621

Review 2.  Systematic review of the role of a belly board device in radiotherapy delivery in patients with pelvic malignancies.

Authors:  Esther M Wiesendanger-Wittmer; Nanna M Sijtsema; Christina T Muijs; Jannet C Beukema
Journal:  Radiother Oncol       Date:  2012-02-22       Impact factor: 6.280

3.  Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance.

Authors:  Lilie L Lin; Lauren Hertan; Ramesh Rengan; Boon-Keng Kevin Teo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-28       Impact factor: 7.038

4.  Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study.

Authors:  Morten Brændengen; Kjell M Tveit; Marianne J Hjermstad; Hemming Johansson; Åke Berglund; Yvonne Brandberg; Bengt Glimelius
Journal:  Eur J Cancer       Date:  2011-07-23       Impact factor: 9.162

5.  Rectal Cancer, Version 2.2015.

Authors:  Al B Benson; Alan P Venook; Tanios Bekaii-Saab; Emily Chan; Yi-Jen Chen; Harry S Cooper; Paul F Engstrom; Peter C Enzinger; Moon J Fenton; Charles S Fuchs; Jean L Grem; Axel Grothey; Howard S Hochster; Steven Hunt; Ahmed Kamel; Natalie Kirilcuk; Lucille A Leong; Edward Lin; Wells A Messersmith; Mary F Mulcahy; James D Murphy; Steven Nurkin; Eric Rohren; David P Ryan; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Kristina M Gregory; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2015-06       Impact factor: 11.908

6.  The effect of treatment position, prone or supine, on dose-volume histograms for pelvic radiotherapy in patients with rectal cancer.

Authors:  M Drzymala; M A Hawkins; A J Henrys; J Bedford; A Norman; D M Tait
Journal:  Br J Radiol       Date:  2009-02-02       Impact factor: 3.039

7.  Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience.

Authors:  Antonella Richetti; Antonella Fogliata; Alessandro Clivio; Giorgia Nicolini; Gianfranco Pesce; Emanuela Salati; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2010-02-19       Impact factor: 3.481

8.  Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.

Authors:  D Tural; M Ozturk; F Selcukbiricik; O Yildiz; O Elicin; H Turna; S Guney; M Ozguroglu
Journal:  J BUON       Date:  2013 Apr-Jun       Impact factor: 2.533

9.  Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus.

Authors:  Salma K Jabbour; Sameh A Hashem; Walter Bosch; Tae Kyoung Kim; Steven E Finkelstein; Bethany M Anderson; Edgar Ben-Josef; Christopher H Crane; Karyn A Goodman; Michael G Haddock; Joseph M Herman; Theodore S Hong; Lisa A Kachnic; Harvey J Mamon; Jason R Pantarotto; Laura A Dawson
Journal:  Pract Radiat Oncol       Date:  2013-08-07

10.  A randomized study of the effect of patient positioning on setup reproducibility and dose distribution to organs at risk in radiotherapy of rectal cancer patients.

Authors:  Trude C Frøseth; Trond Strickert; Kjersti S Solli; Øyvind Salvesen; Gunilla Frykholm; Randi J Reidunsdatter
Journal:  Radiat Oncol       Date:  2015-10-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.